Schrödinger, Inc. (NASDAQ:SDGR) is one of the best healthcare AI stocks to buy now. On December 15, BofA Securities upgraded ...
Earlier in December 2025, BofA Securities upgraded Schrödinger, Inc. after the company shifted away from internal drug development to concentrate on its core computational software business. This ...
Schrodinger is a biotech company that uses machine learning, physics, and chemistry to speed up the drug discovery process, focusing on finding ligands that bind with proteins to treat diseases. The ...
NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, is providing a detailed review of ...
Hosted on MSN
Schrodinger Downgraded By Citi After Ending Blood Cancer Drug Trial Tied To 2 Deaths; Retail Voices Concern
Schrodinger shares came under pressure after Citi pulled back its bullish call, cutting the stock to ‘Neutral’ from ‘Buy’ and slashing its price target to $20 from $35. The firm said recent stumbles ...
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced financial results for the third quarter of 2024 and provided a business update. In a separate press release issued earlier ...
Eli Lilly has joined Schrödinger’s growing stable of drug development partners, putting up $425 million in milestones to access small-molecule candidates against an undisclosed target. Schrödinger has ...
A project to improve data visualization ended up overturning a century-old model of color space that underpins industry standards for color everywhere from digital displays to paint. The opportunity ...
Nobel prize winning scientist Erwin Schrödinger would have been 126 today, the Austrian quantum physicist perhaps most famous for the mind experiment known as Schrödinger’s Cat. Google has celebrated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback